NetworkNewsBreaks

TuesdaySep 05, 2017 9:12 am

NetworkNewsBreaks – Global Payout, Inc. (GOHE) Looks to Achieve Fully Reporting Status within 60 Days

Payment solutions company Global Payout, Inc. (OTC: GOHE) this morning announced that it is currently in the process of completing its financial audit in preparation for the filing of Form 10-K, which the company expects will be completed within the next 60 days. “We are very pleased to have kicked-off the very important process of completing our audit and are optimistic in our ability to complete it within the next 60 days so that we enter a fully reporting status,” James Hancock, CEO of Global Payout, stated in the news release. “By becoming fully reporting, we are increasing our transparency…

Continue Reading

FridaySep 01, 2017 12:54 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on September 1, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: APVO 60.15% – News: Inks end of joint development/commercialization deal with MorphoSys; announces $74.5M agreement to sell hyperimmune commercial products APOP 5.69% – News: Ceasing trade on Tel-Aviv Stock Exchange; exclusively trading on NASDAQ EPIX 3.45% – News: Presenting at the Rodman & Renshaw 19th Annual Global Investment Conference on September 11 MDWD 3.17% – News: Reports top-line results from second cohort of phase 2 clinical trial of EscharEx NETC 2.73% – News: Participating…

Continue Reading

FridaySep 01, 2017 11:13 am

NetworkNewsBreaks – Algae Dynamics Corp. (ADYNF) Profiting within Niche Cannabis Market

The legal cannabis market is exploding in North America and especially in Canada, where medical marijuana has been legal on a national level since 2001 and where sweeping legislation has been introduced in an effort to nationally legalize recreational use, as well. Among cannabis players preparing to capitalize should recreational legalization happen is Algae Dynamics Corp. (OTCQB: ADYNF). An excerpt from an article further discussing this reads: “Algae Dynamics is focused on cannabis oil extraction and medicine delivery systems, endeavoring to offer medical cannabis users a means of enjoying the benefits of medical marijuana without smoking. The company is preparing…

Continue Reading

FridaySep 01, 2017 11:11 am

NetworkNewsBreaks – Revolutionary trutankless Water Heaters from Bollente Companies, Inc. (BOLC) Gain Ground in Thriving Housing Construction Market

The housing construction market in the United States held strong in July 2017, with a seasonal adjusted rate of 1.22 million building permits, 1.15 million privately owned housing starts, and 1.17 million housing completions for private residences reported for the month. Construction trends are tending toward energy-efficient, water-saving multifamily residences in warm climates, which is fueling the demand for tankless water heaters such as those offered through the Bollente Companies, Inc. (OTC: BOLC) trutankless line. An excerpt from an article further discussing this reads: “The company’s industry partnerships for the trutankless line are an important growth driver and include the…

Continue Reading

FridaySep 01, 2017 11:09 am

NetworkNewsBreaks – InMed Pharmaceuticals (CSE: IN) (OTCQB: IMLFF) Could Prove to Be a Cannabis Biotech Unicorn

The recent solar eclipse that enthralled the world has come and gone, but no shadow of an eclipse is on the horizon to blot out the progress of InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF). As peer valuations have soared in Canada’s cannabis market, InMed continues its promising R&D efforts into the therapeutic benefits of marijuana, and this Vancouver, Canada-based company may just prove to be one of the unicorns of Canada’s cannabis biotech market. An excerpt from an article further discussing this reads: “InMed Pharmaceuticals has more to offer than the typical drug discovery and development company. Its triple…

Continue Reading

FridaySep 01, 2017 11:06 am

NetworkNewsBreaks – India Globalization Capital (NYSE: IGC) a Dark Horse in the Race to Treat Alzheimer’s

Alzheimer’s is the most expensive disease in the United States, and pharmaceutical companies are racing to find viable treatments for this devastating disease, which currently affects more than 5.3 million Americans and their loved ones. Wall Street is placing bets on who will win the race to treat Alzheimer’s, and India Globalization Capital (NYSE MKT: IGC) is one promising candidate with a compelling patent-pending treatment protocol. An excerpt from an article further discussing this reads: “IGC is a pioneer in the development of new classes of phytocannabinoid pharmaceuticals with broad therapeutic applications for both humans and animals. IGC’s pipeline of…

Continue Reading

ThursdayAug 31, 2017 12:37 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on August 31, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: EXFO 6.25% – News: Inks deal to acquire a 33.1% equity stake in Astellia KMPH 6.03% – News: Presenting at the Rodman & Renshaw 19th Annual Global Investment Conference on September 11 CRIS 4.30% – News: Presenting at the ESMO 2017 Congress on September 11 RXII 3.51% – News: Presenting at the 8th Annual Investing for Cures Forum on September 7 NDLS 3.42% – News: Partners with No Kid Hungry® to help end childhood…

Continue Reading

ThursdayAug 31, 2017 12:31 pm

NetworkNewsBreaks – Dextera Surgical, Inc.’s (NASDAQ: DXTR) MicroCutter 5/80™ Receives Expanded Indication Approval by FDA; Shares Higher

Dextera Surgical (NASDAQ: DXTR) shares are up 15% this morning after the company said it has received approval from the U.S. Food and Drug Administration (FDA) to use its MicroCutter 5/80 Stapler and MicroCutter 30 White and Curved Tip White Reloads in combination with open solid organ parenchymal dissection techniques, including such organs as the liver, kidney, pancreas and spleen. “This expanded indication represents an additional 44,000 procedures in the United States annually, and we look forward to bringing the MicroCutter 5/80 to surgeons for these applications,” Dextera Surgical president and CEO Julian Nikolchev stated in the news release. To…

Continue Reading

ThursdayAug 31, 2017 12:29 pm

NetworkNewsBreaks – Apricus Biosciences, Inc.’s (NASDAQ: APRI) Vitaros™ Class 2 NDA Resubmission Acknowledged by FDA; PDUFA Goal Date Set

Apricus Biosciences (NASDAQ: APRI) this morning said that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of its recently resubmitted New Drug Application (NDA) for Vitaros™ and considers it a complete, class 2 response to Apricus’ 2008 action letter. Additionally, the PDUFA (Prescription Drug User Fee Act) goal date for conclusion of the FDA’s review is set for the standard review period for NDA resubmissions of six months, falling on February 17, 2018. “The FDA has determined that the resubmission is a complete, class 2 response to our 2008 action letter.  Importantly, we believe that Vitaros, if approved, will…

Continue Reading

ThursdayAug 31, 2017 12:27 pm

NetworkNewsBreaks – SteadyMed (NASDAQ: STDY) Shares Plunge on Refusal to File Letter from FDA for Trevyent® NDA

SteadyMed (NASDAQ: STDY) shares are down 35% this morning after the company said it has received a refusal to file letter from the U.S. Food and Drug Administration (FDA) related to its New Drug Application (NDA) for Trevyent®. The Trevyent NDA was submitted in June 2017 for the treatment of Pulmonary Arterial Hypertension (PAH). Upon preliminary review of the NDA, the FDA determined that it was not adequately complete to permit a substantive review. The FDA has requested more details regarding certain device specifications and performance testing. The FDA also requested further design verification and validation testing on the final,…

Continue Reading